FindTrial
Sign In

Evaluating the Effectiveness of an AI Based Mobile App for Better Management of Atopic Dermatitis

Evaluating the Effectiveness of an AI Enhanced Mobile Application in Improving Management Outcomes for Atopic Dermatitis Patients A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078963
Enrollment
100
Registered
2025-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: AI-enabled mobile application to manage Atopic Dermatitis : AI-enabled mobile application will be used in addition to standard treatment to manage Atopic Dermatitis. The app will includ

Sponsors

IADVL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with atopic dermatitis by a dermatologist. Ages 18 and above. Smartphone users willing to use the app.

Exclusion criteria

Exclusion criteria: Patients with other primary skin disorders. Patients with severe atopic dermatitis requiring systemic therapy. Current participation in another clinical trial.

Design outcomes

Primary

MeasureTime frame
Change in SCORAD (Scoring Atopic Dermatitis) index from baseline to 12 weeks.Timepoint: Change in SCORAD (Scoring Atopic Dermatitis) index from baseline to 12 weeks.—

Secondary

MeasureTime frame
changes in POEM scores, changes in DLQI scores, and patient satisfaction with the AI-enabled application at 12 weeks.Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactNeena Khanna

Amrita Hospital

neena_aiims@yahoo.co.in919312432689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026